Predictive Protein Test Sounds Better Than Personal Genome Service Anyway | GenomeWeb

San Francisco Bay Area-based Tethys Bioscience has received another round of cash on the order of tens of millions, putting their total funding to date at $54 million, says a Wired article. Their test will use protein biomarkers to determine whether someone will become diabetic way before standard diagnostic tests reveal the condition.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.